Zygomatic implants represent one of the most significant advances in treatment options for seniors with severe maxillary bone ...

NEEDHAM, MA, UNITED STATES, February 10, 2026 /EINPresswire.com/ -- Trialt, a global clinical research organization ...

As a CMS-approved QCDR, OneOncology is authorized to collect clinical data from a variety of sources and report MIPS measures for partner practices and their clinicians across all of their EMR ...

Q4 2025 Management View Randy Teel, CEO, stated the company is entering a period with "multiple value-driving milestones," highlighting Arvinas' first new drug application submission, which may lead ...

Sentinel participant showed OPGx-BEST1 was well tolerated with no ocular inflammation, treatment-related adverse events, or ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...

Physicians, struggling under the pressure of heavy patient loads amidst a national clinical workforce shortage, continue to rank working with EHR systems as the second most challenging part of the job ...

BioNTech will present significant clinical trial data at the prestigious ASCO Annual Meeting, highlighting the advancement of its diversified oncology portfolio. The preliminary results for BNT327 and ...

JOURNAVX met the primary endpoint by demonstrating statistically significant superior reduction in pain vs placebo. 1,b JOURNAVX did not meet the first key secondary endpoint that hypothesized ...

Meridian Funds, managed by ArrowMark Partners, released its fourth-quarter 2025 investor letter for “Meridian Small Cap ...

Based on this research output, EYEREUM Eye Clinic currently participates as a member institution of the Korean Ophthalmological Society’s LASIK and LASEK Committee, which reviews clinical ...